ABC | Volume 114, Nº4, April 2020

Original Article Souza et al. Nocturnal BP fall in acute Chagas disease Arq Bras Cardiol. 2020; 114(4):711-715 1. WHO). Sustaining the drive to overcome the global impact of neglected tropical diseases: second WHO report in neglected tropical diseases. Geneva; 2013. 2. Dias JCP, Human Chagas Disease and Migration in the Context Of Globalization: some Particular Aspects. J Trop Med. 2013, ID 789758, 9 pages, doi 10.1155/2013/789758. 3. De Goes EC, Dos Santos SO, Sojo-Milano M, Amador EC, Tatto E, Souza DS, et a 1. WorldHealthOrganization.(l.AcuteChagasdisease intheBrazilianAmazon: epidemiological and clinical features. Int J Cardiol. 2017, 235:176-8. 4. Pinto AY, Ferreira AG Jr, Valente V, Harada GS, Valente AS. Urban outbreak of acute Chagas disease in Amazon region of Brazil: four-year follow-up after treatment with benznidazole. Rev PanamSalud Publica, 2009, 25(1):77-83. 5. Barreto-de-Albuquerque J, Silva-dos-Santos D, Pérez AR, Berbere LR, Santana van Vilet E, Farias deOliveira DA, Moreira OC, et al. Trypanosoma cruzi Infection through the oral route promotes a severe infection in mice: New disease form from an old infection? PLoS Negl Trop Dis. 2015; 9(6):e0003849. 6. Melo ROU, Toledo JCY, Loureiro AAC,Cipullo JP, Moreno Jr H, Martin JF. Absence of Nocturnal Dipping is Associated with Stroke and Myocardium Infarction. Arq Bras Cardiol. 2010; 94(1):74-80. 7. V Diretrizes Brasileiras de Monitorização Ambulatorial da Pressão Arterial (MAPAV) e III Diretrizes Brasileiras deMonitorização Residencial da Pressão Arterial (MRPA III). Sociedades Brasileiras de Cardiologia, Hipertensão e Nefrologia. Arq Bras Cardiol .2011; 97(3 Supl 3):1-24. 8. Correa-Araujo R, Oliveira JS, Cruz AR. Cardiac levels of norepinephrine, dopamine, serotonin and histamine in Chagas’disease. Int J Cardiol. 1991;31(3):329-36. 9. Rassi Jr A, Rassi A, Marin-Neto J. Chagas disease. Lancet. 2010; 375(9723):1388-402. 10. Truccolo AB, Dipp T, Eibel B, Ribeiro A, Casali KR, Irigoyen MC,et al. Associação entre Função Endotelial e a Modulação Autonômica em Pacientes comDoença de Chagas. Arq Bras Cardiol. 2013;100(2):135-40. 11. Oliveira NK, Ferreira RN, Lopes SDN, Chiari E, Camargos ERDS, Martinelli PM. Cardiac autonomic denervation and expression of neurotrophins (NGF and BDNF) and their receptors during experimental Chagas disease. Growth Factors. 2017;35(4-5):161-70. 12. E, Pérez AR, Pollachini N,Villar SR, Wildman J, Besedovsky H, et al. The sympathetic nervous system affects the susceptibility and course of Trypanosoma cruzi infection. Brain Behav Immun.2016 Nov;58:228-36. 13. Amorim DS, Godoy RA, Mango JC, Tanaka A, Gallo Jr L. Effects of acute elevation in blood pressure and of atropine on heart rate in Chagas’ disease. A preliminary report. Circulation.1968; 38(2):289-94. 14. Simoes MV, Pintya AO, Bromberg-Marin G, Sarabanda A, Antioga CM, et al. Relation of regional sympathetic denervation and myocardial perfusion disturbance to wall motion impairment in chagas’ cardiomyopathy. Am J Cardiol 2000;86(9):975-81. 15. Koberle F. Enteromegaly and cardiomegaly in Chagas disease. Gut 1963; 4(4):399-405. 16. Staessen JA, Bieniaszewski L, O’Brien E, Gosse P, Havashi H, Imai Y, et al. Nocturnal blood pressure fall on ambulatory monitoring in a large international database. The “AdHoc’Working Group. Hypertension .1997; 29(1Pt 1):30–9. 17. Murali NS, Svatikova A, Somers VK. Cardiovascular physiology and sleep. Front Biosci. 2003 June; 8:S636-S652. 18. Dodt C, Breckling U, Derad I, Plasma epinephrine and norepinephrine concentrations of healthy humans associated with nighttime sleep and morning arousal. Hypertension. 1997;30(1):71-6. 19. Souza DSM , Póvoa RMS. Aspectos epidemiológicos e clínicos da doença de Chagas aguda no Brasil e na América Latina. Rev Soc Cardiol Estado de São Paulo. 2016;26(4):222-9. References 714